4-methoxyamphetamine has been researched along with Cancer, Second Primary in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bundoc, F; Chan, N; Finkelstein, E; Malhotra, C; Malhotra, R; Ozdemir, S; Teo, I | 1 |
Conroy, T; Henry, A; Minot, L; Salleron, J | 1 |
JAKOBOVITS, A | 1 |
Amemiya, Y; Hasegawa, J; Noguchi, I; Seto, K | 1 |
4 other study(ies) available for 4-methoxyamphetamine and Cancer, Second Primary
Article | Year |
---|---|
Trajectories of Suffering in the Last Year of Life Among Patients With a Solid Metastatic Cancer.
Topics: Anxiety; Death; Humans; Neoplasms; Neoplasms, Second Primary; Prospective Studies; Terminal Care | 2021 |
[Examining the use of palliative systemic treatments near end-of-life for patients with metastatic cancer at a French cancer institute].
Topics: Adult; Death; Humans; Neoplasms; Neoplasms, Second Primary; Palliative Care; Retrospective Studies; Terminal Care | 2023 |
[Cause of death and anatomical distribution of metastases in uterine cancer].
Topics: Cause of Death; Death; Female; Humans; Neoplasms, Second Primary; Uterine Neoplasms | 1957 |
Postoperative death of a patient in apparent remission of malignant lymphoma after dissection for squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Death; Disseminated Intravascular Coagulation; Humans; Immunocompromised Host; Immunosuppression Therapy; Lymphoma, Non-Hodgkin; Male; Mandibular Neoplasms; Multiple Organ Failure; Neoplasms, Second Primary; Postoperative Complications; Recurrence; Remission Induction | 1992 |